AviadoBio will combine its proprietary vMiX™ RNAi platform with Apertura’s novel human TfR1 capsid (TfR1 CapX™) to enable one ...
Programmable circRNA platform achieves near-complete B cell depletion in non-human primates using targeted in vivo CAR-T deliveryBOSTON--(BUSINESS WIRE)--Strand Therapeutics, a clinical-stage ...
Oral presentation will highlight new interim clinical data from the ongoing POLARIS studies; additional posters showcase broader platform capabilities -SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...
Toshiba and the National Science Teaching Association (NSTA) honor student innovation with prizes and award ceremony in Washington, D.C.
Sample technologies, QIAcuity and QDI deliver solid growth; QuantiFERON sales affected by significantly lower immigration ...
Coramitug is a potential best-in-class amyloid depleter antibody for the treatment of ATTR amyloidosis with cardiomyopathy1-3Coramitug is being evaluated by Novo Nordisk in the ongoing Phase 3 ...
GARDEN GROVE, CA / ACCESS Newswire / April 27, 2026 / Recovery Beach, a premier detox and residential treatment facility near Anaheim, California, is reopening April 27th with a new Executive Director ...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today ...
ThinkTrends agentic Document AI platform has been deployed at the U.S. Food and Drug Administration (FDA) as part of its new nationwide Adverse Event Monitoring System (AEMS), a major modernization ...
New specialty drug benefits research shows growing focus on medical-benefit drugs, rising interest in trading rebates for ...
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for ...
Witnessing the Full Launch of the "Dual Taiwan-U.S. Production Base" StrategyBURLINGTON, Mass.--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results